A carregar...

Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells

OBJECTIVES: Chronic infections with the opportunistic pathogen Pseudomonas aeruginosa are responsible for the majority of the morbidity and mortality in patients with cystic fibrosis (CF). While P. aeruginosa infections may initially be treated successfully with standard antibiotics, chronic infecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Lashua, Lauren P., Melvin, Jeffrey A., Deslouches, Berthony, Pilewski, Joseph M., Montelaro, Ronald C., Bomberger, Jennifer M.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4954927/
https://ncbi.nlm.nih.gov/pubmed/27231279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!